0 companies available
↑ ↓ to navigate Enter to select Esc to close
ELI LILLY & Co
LLY
Pharmaceutical Preparations Last filing · Quarter 2 · Jun 30, 2026Export XLSX
| Ratios | LTM | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Margin | 83.40% | 83.04% | 81.31% | 79.25% | ||||||||||||||
Operating Margin | 42.22% | 40.35% | 28.64% | 18.92% | ||||||||||||||
Pretax Margin | 42.17% | 39.48% | 28.15% | 19.21% | ||||||||||||||
Effective Tax Rate | 20.49% | 19.79% | 16.49% | 20.05% | ||||||||||||||
Net Margin | 33.53% | 31.67% | 23.51% | 15.36% | ||||||||||||||
Current Ratio | - | 1.58x | 1.15x | 0.94x | ||||||||||||||
Debt to Equity | - | 3.24x | 4.52x | 4.89x | ||||||||||||||
Net Debt to Equity | - | 2.96x | 4.29x | 4.63x | ||||||||||||||
Asset Turnover | - | 57.95% | 57.22% | 53.31% | ||||||||||||||
Return on Equity | - | 77.78% | 74.20% | 48.24% | ||||||||||||||
Return on Assets | - | 18.35% | 13.45% | 8.19% |